Literature DB >> 2612342

The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus.

K Shima1, F Abe, H Chikakiyo, N Ito.   

Abstract

We compared the usefulness of three glycated serum proteins, glycated albumin (GA), glycated hemoglobin (HBA1c) and fructosamine (FA), for diabetic screening purposes. We measured these indices in 302 adults, most of whom underwent yearly physical examinations. We measured GA and HbA1c with high precision using high-performance liquid chromatography (interassay coefficients of variation 4.9 and 4.0%, respectively) and FA using commercial reagents (interassay coefficient of variation 1.65%). All the individuals underwent a 75-g oral glucose tolerance test, which revealed significant correlations between the values of the three glycated proteins and the four plasma glucose concentrations measured as well as the sum of these glucose concentrations, sigma BS (GA, r = 0.80; HbA1c, r = 0.80; FA, r = 0.65). On the basis of the test, 130 of the subjects were classified as normal (N), 123 as borderline and 49 as having diabetes mellitus (D) according to the criteria of the Japan Diabetes Society. Of the 123 borderline cases, 26 showed impaired glucose tolerance (IGT) according to the WHO criteria. The normal group values of GA, HbA1c and FA were 17.8 +/- 0.17% (mean +/- SEM), 5.02 +/- 0.03%, and 2.55 +/- 0.02 mM/l, respectively. Borderline and IGT subjects had significantly more GA and HbA1c than normal but not more FA (P less than 0.01). We divided the subjects into 10 groups on the basis of their sigma BS values; those with values higher than 671 +/- 4.7 mg/dl had significantly more GA and HbA1c than normal, while those with values higher than 1068 +/- 40.9 mg/dl (the most extreme cases) had significantly more FA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612342     DOI: 10.1016/0168-8227(89)90011-9

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

1.  A1C Combined With Glycated Albumin Improves Detection of Prediabetes in Africans: The Africans in America Study.

Authors:  Anne E Sumner; Michelle T Duong; Paola C Aldana; Madia Ricks; Marshall K Tulloch-Reid; Jay N Lozier; Stephanie T Chung; David B Sacks
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

2.  Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions.

Authors:  Kerry J Welsh; M Sue Kirkman; David B Sacks
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

3.  Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.

Authors:  Christine L Chan; Laura Pyle; Megan M Kelsey; Lindsey Newnes; Amy Baumgartner; Philip S Zeitler; Kristen J Nadeau
Journal:  Pediatr Diabetes       Date:  2016-11-22       Impact factor: 4.866

4.  Glycated albumin is associated with body mass index in euglycemic adults but is not predictive of postprandial blood glucose response.

Authors:  Andrew N Reynolds; Ashley Duncan; Devonia Kruimer; Bernard J Venn
Journal:  J Clin Lab Anal       Date:  2016-10-24       Impact factor: 2.352

Review 5.  Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities.

Authors:  Jean C Dinh; Chelsea M Hosey-Cojocari; Bridgette L Jones
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

Review 6.  Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.

Authors:  Elisa Danese; Martina Montagnana; Antonio Nouvenne; Giuseppe Lippi
Journal:  J Diabetes Sci Technol       Date:  2015-01-14

7.  A review of glycated albumin as an intermediate glycation index for controlling diabetes.

Authors:  H Vernon Roohk; Asad R Zaidi
Journal:  J Diabetes Sci Technol       Date:  2008-11

8.  Improved Detection of Abnormal Glucose Tolerance in Africans: The Value of Combining Hemoglobin A1c With Glycated Albumin.

Authors:  Arsene F Hobabagabo; Nana H Osei-Tutu; Thomas Hormenu; Elyssa M Shoup; Christopher W DuBose; Lilian S Mabundo; Joon Ha; Arthur Sherman; Stephanie T Chung; David B Sacks; Anne E Sumner
Journal:  Diabetes Care       Date:  2020-08-14       Impact factor: 19.112

Review 9.  Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases.

Authors:  Rosaria Vincenza Giglio; Bruna Lo Sasso; Luisa Agnello; Giulia Bivona; Rosanna Maniscalco; Daniela Ligi; Ferdinando Mannello; Marcello Ciaccio
Journal:  J Clin Med       Date:  2020-11-11       Impact factor: 4.241

Review 10.  Novel biomarkers for prediabetes, diabetes, and associated complications.

Authors:  Brenda Dorcely; Karin Katz; Ram Jagannathan; Stephanie S Chiang; Babajide Oluwadare; Ira J Goldberg; Michael Bergman
Journal:  Diabetes Metab Syndr Obes       Date:  2017-08-14       Impact factor: 3.168

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.